Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Cascade Financial Partners, LLC | 108.8K | -- | 1.73% | +92.4K | 2026-06-30 |
| Fund Evaluation Group, LLC | 51.8K | -- | 0.83% | -- | 2026-06-30 |
| Geode Capital Management, LLC | 30.3K | -- | 0.48% | +690 | 2026-06-30 |
| Vanguard Capital Management LLC | 27.8K | -- | 0.44% | -39.9K | 2026-06-30 |
| Qube Research & Technologies Ltd | 24.3K | -- | 0.39% | -- | 2026-06-30 |
| BlackRock, Inc. | 18.2K | -- | 0.29% | -6.4K | 2026-06-30 |
| Vanguard Fiduciary Trust Co | 6.4K | -- | 0.10% | -- | 2026-06-30 |
| Tower Research Capital LLC (TRC) | 4.7K | -- | 0.08% | -- | 2026-06-30 |
| Osaic Holdings, Inc. | 2.4K | -- | 0.04% | -- | 2026-06-30 |
| UBS Group AG | 1.1K | -- | 0.02% | -4.6K | 2026-06-30 |
